Amid the rollout of the world's largest Covid-19 vaccination programme by Prime Minister Narendra Modi, here are a few things that you need to know about the two vaccines -- 'Covaxin' and 'Covishield' -- selected by the Drugs Controller General of India (DCGI).
Punjab Chief Minister Amarinder Singh on Friday wrote to Prime Minister Narendra Modi, seeking free COVID-19 vaccination for the poor in the state.
Prime Minister Narendra Modi on Saturday will kick start the world's largest vaccination drive against coronavirus, almost a year after India reported the first case of the deadly infectious disease, which has claimed over 1.5 lakh lives in the country till now. It is going to be a historic moment with the commencement of the eagerly-awaited vaccination drive against the dreaded disease.
As country after country approves vaccine to fight coronavirus, India's neighbour Nepal has also approved use of AstraZeneca Covishield vaccine manufactured in India, Reuters reported quoting Nepal Government.
Brazil is planning to send a special flight to Mumbai to lift at least two million doses of Covid-19 vaccine.
According to the Union Health Ministry, the comparison parameters will include vaccine platform, physical specifications, dosage, cold chain storage requirements, and minor adverse events following the immunisation.
The Delhi government is expecting to scale up the vaccination centres to 225 within a week of the Covid-19 immunisation programme launch, officials informed.
India's vaccination drive against Covid-19 will be launched at around 3,000 sites on January 16 and the number of sites will be ramped up to 5,000 by the end of the month.
As vaccines against coronavirus reaching corners of India during mass distribution drive underway ahead of January 16 launch, the robust preparations ahead of the D-day when the world's biggest immunization exercise against the Covid-19 starts, are underway at the national capital too.
India is now geared to start its first phase of vaccination drive from January 16 with priority given to an estimated three crore healthcare workers and frontline workers.
AIIMS scientist Sanjay Rai reveals that according to the pieces of evidence gathered in the last one year, people who have tested COVID19 positive do not need the vaccine currently.
A minimum of 100 people will be vaccinated against COVID-19 at a single centre which will have a team of five personnel who will verify the SMS sent to the person to be inoculated, her or his identity and administer the vaccine.
A SpiceJet flight carrying the vaccines left for the national capital around 8 am, three hours after three trucks with the maiden consignment of the vaccines rolled out of the Serum Institute of India facility, 15 km from the airport.
Three temperature-controlled trucks rolled out of the Serum Institute gates shortly before 5 am and left for Pune airport, from where the vaccines will be flown across India.
Almost a year into the COVID-19 pandemic, about 200 vaccine candidates are in the works and 10 have been either approved by several countries or are under limited emergency use.
The vaccination drive against coronavirus will kick off on January 16, 2021. The priority will be given to the healthcare workers and the frontline workers, estimated to be around 3 crore, followed by those above 50 years and the under-50 population groups with co-morbidities numbering around 27 crore, the government said on Saturday.
As India gets closer to mass vaccination nation-wide rollout, it must brace up to tackle vaccine misinformation on a war footing.
A second dry run to check the best way to vaccinate people against COVID-19 is taking place across 737 districts in the country today.
In a shift from practices in the U.S. and elsewhere, Britain plans to give people second doses of both vaccines within 12 weeks of the first shot rather than within 21 days, to accelerate immunizations across as many people as quickly as possible.
The Serum Institute of India, the world's largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield, while Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Top News
Latest News
